| Authors: |
Beaufort CM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Helmijr JC; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Piskorz AM; Functional Genomics of Ovarian Cancer Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom., Hoogstraat M; Department of Medical Oncology and Center for Personalized Cancer Treatment, University Medical Center Utrecht, Utrecht The Netherlands., Ruigrok-Ritstier K; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Besselink N; Department of Medical Oncology and Center for Personalized Cancer Treatment, University Medical Center Utrecht, Utrecht The Netherlands., Murtaza M; Molecular and Computational Diagnostics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., van IJcken WF; Center for Biomics, Erasmus MC, Rotterdam, The Netherlands., Heine AA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Koudijs MJ; Department of Medical Oncology and Center for Personalized Cancer Treatment, University Medical Center Utrecht, Utrecht The Netherlands., Brenton JD; Functional Genomics of Ovarian Cancer Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom., Berns EM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Helleman J; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. |
